Cargando…

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy

Background Many chemotherapeutic agents, especially taxanes, can induce peripheral neuropathy. Aim To evaluate the clinical characteristics of taxane-induced neuropathy (TIN) and determine the proper assessment tool for TIN in patients with breast cancer. Setting and Design Single-center, observatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sohn, Eun Hee, Lee, Jin Sun, Jung, Mi Sook, Kim, Je Ryong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Private Ltd 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460343/ https://www.ncbi.nlm.nih.gov/pubmed/34568215 http://dx.doi.org/10.1055/s-0041-1731100

Ejemplares similares

The impact of SBF2 on taxane-induced peripheral neuropathy
por: Cunningham, Geneva M., et al.
Publicado: (2022)

Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial
por: Jeong, Young Ju, et al.
Publicado: (2018)

Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
por: Rivera, Edgardo, et al.
Publicado: (2015)

Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
por: Jia, Junting, et al.
Publicado: (2021)

Melatonin, a Promising Role in Taxane-Related Neuropathy
por: Nahleh, Z., et al.
Publicado: (2010)

Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
por: van Haren, Frank, et al.
Publicado: (2021)

Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study
por: Dorand, R. Dixon, et al.
Publicado: (2023)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
por: Simsek, Neriman Yükseltürk, et al.
Publicado: (2018)

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer
por: Mo, Hongnan, et al.
Publicado: (2022)

Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology
por: Chen, Emily I., et al.
Publicado: (2015)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019)

Taxane-Induced Neuropathy and Its Ocular Effects—A Longitudinal Follow-up Study in Breast Cancer Patients
por: Stache, Nadine, et al.
Publicado: (2023)

Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review
por: Schwab, Lauren, et al.
Publicado: (2023)

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
por: Anoop, T M, et al.
Publicado: (2022)

A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy
por: Ibrahim, Eiman Y., et al.
Publicado: (2022)

Acetyl-L-carnitine for the prevention of taxane-induced neuropathy in patients with breast cancer: a systematic review and meta-analysis
por: Momenzadeh, Mahnaz, et al.
Publicado: (2023)

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans
por: Schneider, Bryan P., et al.
Publicado: (2016)

Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy
por: Bandla, Aishwarya, et al.
Publicado: (2019)

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol
por: Sharma, Anukriti, et al.
Publicado: (2022)

Investigating the Effect of Zinc on the Prevention of Acute Peripheral Neuropathy in Cancer Patients Treated with Taxanes
por: Haji Gholami, Ali, et al.
Publicado: (2022)

Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015)

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients
por: Tanabe, Yuko, et al.
Publicado: (2020)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Incidence density and factors associated with peripheral neuropathy among women with breast cancer during taxane-based chemotherapy
por: Rattanakrong, Nida, et al.
Publicado: (2022)

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
por: Mitin, Natalia, et al.
Publicado: (2022)

The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial
por: Avan, Razieh, et al.
Publicado: (2018)

Taxane-Induced Upper Gastrointestinal Bleeding
por: Liu, Yao, et al.
Publicado: (2021)

Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors
por: Knoerl, Robert, et al.
Publicado: (2021)

Taxanes for the Treatment of Metastatic Breast Cancer
por: Gradishar, W.J.
Publicado: (2012)

Cold Application and Exercise on Development of Peripheral Neuropathy during Taxane Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial
por: Şimşek, Neriman Yükseltürk, et al.
Publicado: (2021)

CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane
por: Ahn, Jin-Hee, et al.
Publicado: (2004)

Symptoms of anxiety but not depression before start of taxane-based chemotherapy are associated with peripheral neuropathy: a multicenter study in women with breast cancer
por: Verhoeff-Jahja, Rita, et al.
Publicado: (2022)

Corrigendum: CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

Optimal use of taxanes in metastatic breast cancer
por: King, K.M., et al.
Publicado: (2009)

Taxanes in the elderly patient with metastatic breast cancer
por: Yardley, Denise A
Publicado: (2015)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
por: Kianersi, Shirin, et al.
Publicado: (2023)

Taxane-induced morphea in a patient with CREST syndrome
por: Bouchard, Susan M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lg14pe03dl2hh7545c76a1rki7